364 related articles for article (PubMed ID: 28099778)
1. Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center.
Pande A; Non LR; Romee R; Santos CA
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28099778
[TBL] [Abstract][Full Text] [Related]
2. Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.
Thien SY; Chung SJ; Tan AL; Hwang WY; Tan BH; Tan TT
Transpl Infect Dis; 2016 Oct; 18(5):768-772. PubMed ID: 27425395
[TBL] [Abstract][Full Text] [Related]
3. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
[TBL] [Abstract][Full Text] [Related]
4. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.
Chitasombat MN; Kofteridis DP; Jiang Y; Tarrand J; Lewis RE; Kontoyiannis DP
J Infect; 2012 Jan; 64(1):68-75. PubMed ID: 22101079
[TBL] [Abstract][Full Text] [Related]
5. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Ramírez I; Moncada D
Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
[TBL] [Abstract][Full Text] [Related]
6. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
Kimura M; Araoka H; Yamamoto H; Nakamura S; Nagi M; Yamagoe S; Miyazaki Y; Ogura S; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Shimazu H; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
[TBL] [Abstract][Full Text] [Related]
7. [A rare and mortal infection agent in patients with hematological malignancies: Saprochaete capitata].
Aydın Kaynar L; Özkurt ZN; Ülküden B; Güzel Tunçcan Ö; Aygencel G; Akyürek N; Kalkancı A
Mikrobiyol Bul; 2016 Oct; 50(4):613-620. PubMed ID: 28124967
[TBL] [Abstract][Full Text] [Related]
8. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
[TBL] [Abstract][Full Text] [Related]
9. Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Fanci R
J Chemother; 2009 Feb; 21(1):105-7. PubMed ID: 19297283
[No Abstract] [Full Text] [Related]
10. Pseudozyma spp. human infections: A systematic review.
Telles JP; Ribeiro VST; Kraft L; Tuon FF
Med Mycol; 2021 Jan; 59(1):1-6. PubMed ID: 32343341
[TBL] [Abstract][Full Text] [Related]
11. Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Okamoto T; Koh K; Takita J; Furuya A; Kato M; Ida K
Pediatr Int; 2010 Feb; 52(1):137-41. PubMed ID: 20158658
[No Abstract] [Full Text] [Related]
12. First neonatal case of fungaemia due to Pseudozyma aphidis and a global literature review.
Prakash A; Wankhede S; Singh PK; Agarwal K; Kathuria S; Sengupta S; Barman P; Meis JF; Chowdhary A
Mycoses; 2014 Jan; 57(1):64-8. PubMed ID: 23834440
[TBL] [Abstract][Full Text] [Related]
13. Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review.
Siddiqui W; Ahmed Y; Albrecht H; Weissman S
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25498807
[TBL] [Abstract][Full Text] [Related]
14. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
[TBL] [Abstract][Full Text] [Related]
15. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Gahn B; Schub N; Repp R; Gramatzki M
Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709
[TBL] [Abstract][Full Text] [Related]
16. Three cases of Candida fermentati fungemia following hematopoietic stem cell transplantation.
Morita K; Honda A; Koya J; Toyama K; Ikeda M; Misawa Y; Okugawa S; Nakamura F; Moriya K; Kurokawa M
J Infect Chemother; 2018 Jul; 24(7):576-578. PubMed ID: 29371065
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous Infection Associated with Trichosporon ovoides: A Case Report and Review of Literature.
Mohd Tap R; Sabaratnam P; Ramli NY; Hashim R; Mohd Fuat AR; Ng PP; Khairam H; Ahmad N
Mycopathologia; 2016 Apr; 181(3-4):285-90. PubMed ID: 26493614
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy of micafungin and liposomal amphotericin B].
Saitoh T; Matsushima T; Shimizu H; Osaki Y; Yamane A; Irisawa H; Yokohama A; Uchiumi H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H
Rinsho Ketsueki; 2008 Feb; 49(2):94-8. PubMed ID: 18341039
[TBL] [Abstract][Full Text] [Related]
19. Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
Scott RS; Sutton DA; Jagirdar J
Ann Diagn Pathol; 2005 Aug; 9(4):227-30. PubMed ID: 16084458
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
Montesinos P; Rodríguez-Veiga R; Boluda B; Martínez-Cuadrón D; Cano I; Lancharro A; Sanz J; Arilla MJ; López-Chuliá F; Navarro I; Lorenzo I; Salavert M; Pemán J; Calvillo P; Martínez J; Carpio N; Jarque I; Sanz GF; Sanz MA
Bone Marrow Transplant; 2015 Nov; 50(11):1465-72. PubMed ID: 26281032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
